Skip to main content
PMC home page
Wiley - PMC COVID-19 Collection logoLink to Wiley - PMC COVID-19 Collection
. 2006 Apr 27;24(5):457–464. doi: 10.1111/j.1365-2222.1994.tb00934.x

Amplified rhinovirus colds in atopic subjects

P G BARDIN 1,✉, D J FRAENKEL 1, G SANDERSON 1, M DORWARD 1, L C K LAU 1, S L JOHNSTON 1, S T HOLGATE 1
PMCID: PMC7164826  PMID: 8087657

Abstract

Abstract. Evidence suggests that atopic individuals may be predisposed to more severe rhinoviral colds coupled to a worsening of existing airway disease than those with asthma. The role of atopy and IgE levels, as well as their relationship to clinical disease expression have not been defined. We hypothesized that an allergic diathesis modulates rhinoviral colds and have initiated studies of normal, atopic and asthmatic subjects employing experimental rhinoviral infection, with measurements of symptom scores, viral shedding and cultures, albumin in nasal washes and serological responses. Twenty‐two subjects (11 normal, 5 atopic, 6 atopic and asthmatic) participated and were inoculated with human rhinovirus serotype 16 (HRV 16). Measurements of neutralizing antibody and viral culture were performed at screening, pre‐inoculation, during the cold and at 8–10 weeks convalescence. Daily symptoms were noted, nasal washes done, IgE measured and atopy was diagnosed by skin tests. Seventeen volunteers developed clinical colds as assessed by symptom scores, virus shedding was demonstrated (with positive culture) in all subjects and a fourfold or higher seroconversion occurred in 11/22. Neutralizing HRV antibody developed unexpectedly in 10 subjects between screening and inoculation and the presence or absence of this pre‐inoculation antibody determined subsequent severity of colds in normal but not in atopic subjects. Atopic antibody positive individuals developed severe clinical colds that were independent of preinoculation antibody in contrast to normal subjects who developed mild colds in the presence of a neutralizing antibody (.P= 0.01). Both atopic and normal antibody negative subjects developed severe colds. This differential response was matched by nasal wash albumin levels which were significantly increased (P= 0–01) during the cold in atopic (but not in normal) volunteers with pre‐inoculation antibody. Levels of IgE were not correlated with severity of clinical disease or viral shedding. Our studies of HRV disease in atopic subjects suggest heightened susceptibility to the detrimental effects of colds; additional studies are needed to clarify the relevant mechanisms.

References

  • 1. Johnston S, Pattemore P, Smith S, et al. The association of viral infections with longitudinal changes in respiratory symptoms and/or peak flow recordings in schoolchildren. Eur Resp J 1992; 5:109. [Google Scholar]
  • 2. Lemanske RF Jr, Dick EC, Swenson CA, Vrtis RF, Busse WW. Rhinovirus upper respiratory infection increases airway hyperreactivity and late asthmatic reactions. J Clin Invest 1989; 83:1–10. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3. Jackson GG, Dowling HF. Transmission of the common cold to volunteers under controlled conditions. IV. Specific immunity to the common cold. J Clin Invest 1959; 38:762–9. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4. Cate TR, Couch RB, Johnson KM. Studies with Rhinoviruses in volunteers: Production of illness, effect of naturally acquired antibody, and demonstration of a protective effect not associated with serum antibody. J Clin Invest 1964; 43:56–67. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5. Calhoun WJ, Swenson CA, Dick EC et al. Experimental Rhinovirus 16 infection potentiates histamine release after antigen bronchoprovocation in allergic subjects. Am Rev Respir Dis 1991; 144:1267–73. [DOI] [PubMed] [Google Scholar]
  • 6. Doyle WJ, Skoner DP, Fireman P et al. Rhinovirus 39 infection in allergic and nonallergic subjects. J Allergy Clin Immunol 1992; 89:968–78. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7. Jackson GG, Dowling HF, Spiesman IG, Boand AV. Transmission of the common cold to volunteers under controlled conditions. Arch Int Med 1958; 101:267–78. [DOI] [PubMed] [Google Scholar]
  • 8. Cohen S, Tyrrell DA, Russell MAH, Jarvis MJ, Smith AP. Smoking, alcohol consumption, and susceptibility to the Common Cold. Am J Public Health 1993; 83:1277–83. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9. Weeke B. Rocket immunoelectrophoresis. Scand J Immunol 1973; 1:37–46. [DOI] [PubMed] [Google Scholar]
  • 10. Hendley JO, Edmondson WP Jr, Gwaltney JM Jr. Relation between naturally acquired immunity and infectivity of two Rhinoviruses in volunteers. J Infect Dis 1972; 125:243–8. [DOI] [PubMed] [Google Scholar]
  • 11. Matsuse T, Hayashi S, Kuwano K et al. Latent adenoviral infection in the pathogenesis of chronic airways obstruction. Am Rev Respir Dis 1992; 146:177–84. [DOI] [PubMed] [Google Scholar]
  • 12. Halperin SA, Eggleston PA, Beasley P et al. Exacerbations of asthma in adults during experimental rhinovirus infection. Am Rev Respir Dis 1985; 132:976–80. [DOI] [PubMed] [Google Scholar]
  • 13. Cohen S, Tyrrell DAJ, Smith AP. Psychological stress and susceptibility to the common cold. New Engl J Med 1991; 325,9:606–12. [DOI] [PubMed] [Google Scholar]
  • 14. Couch RB, Gate TR, Douglas GR Jr, Geronc PJ, Knight V. Effect of route of inoculation on experimental respiratory viral disease in volunteers and evidence for airborne transmission. Bacteriol Rev 1966; 30:517–29. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15. D'Alessio DJ, Peterson JA, Dick CR, Dick EC. Transmission of experimental Rhinovirus colds in volunteer married couples. J Infect Dis 1976; 133:28–36. [DOI] [PubMed] [Google Scholar]
  • 16. Naclerio RM, Lichtenstein LM Kagey‐Sobotka A, et al. Kinins are generated during experimental rhinovirus colds. J Infect Dis 1988; 157:133–42. [DOI] [PubMed] [Google Scholar]
  • 17. Wiselka MJ, Kent J, Cookson JB, Nicholson KG. Impact of respiratory virus infection in patients with chronic chest disease. Epidemiol Infect 1993; 111:337–46. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18. Callow KA, Tyrrell DAJ, Shaw RJ et al. Influence of atopy on the clinical manifestations of coronavirus infection in adult volunteers. Clin Allergy 1988; 18:119–29. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19. Cooney MK, Wise JA, Kenny GE, Fox JP. Broad antigenic relationships among Rhinovirus serotypes revealed by cross‐immunization of rabbits with different serotypes. J Immunol 1975; 114:635–9. [PubMed] [Google Scholar]
  • 20. Mufson MA, Ludwig WM, James HD Jr et al. Effect of neutralizing antibody on experimental Rhinovirus infection. JAMA 1963; 186:578–84. [DOI] [PubMed] [Google Scholar]
  • 21. Bardin PG, Johnston SL, Pattemore PK. Viruses as precipitants of asthma symptoms II. Physiology and mechanisms. Clin Exp Allergy 1992; 22:809–22. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22. Johnston SL, Bardin PG, Pattemore PK.. Viruses as precipitants of asthma symptoms III. Rhinoviruses: molecular biology and prospects for future intervention. Clin Exp Allergy 1993; 23:237–46. [DOI] [PubMed] [Google Scholar]

Articles from Clinical and Experimental Allergy are provided here courtesy of Wiley

RESOURCES